Sanofi-Aventis A.E.B.E.
Sanofi-Aventis A.E.B.E., a prominent player in the pharmaceutical industry, is headquartered in Greece (GR) and operates extensively across Europe and beyond. Founded in 2004, the company has established itself as a leader in research and development, focusing on innovative healthcare solutions that address unmet medical needs. Sanofi-Aventis is renowned for its diverse portfolio, which includes prescription medicines, vaccines, and consumer healthcare products. Their commitment to quality and innovation sets them apart in a competitive market. With a strong emphasis on therapeutic areas such as diabetes, oncology, and rare diseases, the company has achieved significant milestones, solidifying its position as a trusted name in the healthcare sector.
DitchCarbon Score
How does Sanofi-Aventis A.E.B.E.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sanofi-Aventis A.E.B.E.'s score of 57 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sanofi-Aventis A.E.B.E.'s reported carbon emissions
Sanofi-Aventis A.E.B.E., headquartered in Greece (GR), currently does not have available carbon emissions data for the most recent year. As a result, specific figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions, are not provided. In the absence of detailed emissions data, it is important to note that the company has not outlined any specific reduction targets or initiatives related to carbon emissions. This lack of publicly available information on their climate commitments suggests that Sanofi-Aventis A.E.B.E. may still be in the process of developing or formalising their sustainability strategies. As the pharmaceutical industry increasingly prioritises climate action, it is essential for companies like Sanofi-Aventis A.E.B.E. to establish clear targets and transparent reporting to align with global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sanofi-Aventis A.E.B.E. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
